Exam 2 Everything

Overview of Attention Deficit Hyperactivity Disorder (ADHD)

  • Definition and Characteristics: Attention Deficit Hyperactivity Disorder (ADHD) is a neurodevelopmental disorder primarily defined by symptoms of hyperactivity, inattention, and impulsivity.

  • Prevalence: It is one of the most common childhood neurodevelopmental disorders, affecting approximately 7%7\% of children and adolescents worldwide. While it begins in early childhood, it persists into adulthood in most cases.

  • Etiology: The cause of ADHD is multifactorial, involving both genetic and environmental factors that contribute to its phenotypic heterogeneity. Diet is considered a significant modifiable environmental factor.

  • Economic Impact:

    • United Kingdom: The mean annual cost per adolescent for the National Health Service, social care, and education related to ADHD was reported as GBP 5493GBP\,5493.

    • Spain: In 20122012, the estimated average cost was EUR 5733EUR\,5733 per child/adolescent per year. Pharmacotherapy accounts for 25.8%25.8\% of direct costs and 15.5%15.5\% of total costs.

  • Comorbidities: Several comorbidities often emerge along the developmental trajectory, including impaired executive function and emotional dysregulation.

Diagnosis and Conventional Treatment Modalities

  • Diagnostic Criteria (DSM-5): Diagnosis requires at least six symptoms of inattention and/or hyperactivity-impulsivity. These must be present before the age of 1212 years, occur in two or more settings, and interfere with functioning. Symptoms are categorized as predominantly inattentive, predominantly hyperactive, or combined.

  • Clinical Evaluation: Assessment involves a comprehensive clinical and psychosocial evaluation and a full psychiatric history.

  • Validated Rating Scales: Used to collect data from parents, teachers, and caregivers. Examples include:

    • Conners Comprehensive Behavior Rating Scales.

    • NICHQ Vanderbilt Assessment Scale.

    • ADHD-RS-V.

    • SNAP-IV-26.

    • Strengths and Difficulties Questionnaire (SDQ).

  • Pharmacological Interventions:

    • Stimulants: Methylphenidate and amphetamine formulations. Side effects include decreased appetite, weight loss, insomnia, abdominal pain, anxiety, and a decrease in growth rate (with no indicated growth rebound).

    • Non-stimulants:

      • Atomoxetine (selective norepinephrine reuptake inhibitor): Side effects include headaches, somnolence, and nausea. Rare liver injuries and suicidal thoughts in children have been noted.

      • Selective alpha-2 adrenergic agonists: Guanfacine and Clonidine. Side effects include sedation, fatigue, irritability, and upper abdominal pain.

  • Psychological Therapies: Includes behavioral therapy, cognitive training, and neurofeedback. Behavioral therapy combined with stimulants is generally more effective than medication alone.

The Relationship Between Dietary Patterns and ADHD Risk

  • Dietary Pattern Analysis: This approach provides a holistic understanding of nutrient interactions rather than looking at isolated nutrients. Recent global shifts in diet (increased reliance on processed foods, take-away meals, and sugar-sweetened beverages) have impacted ADHD prevalence.

  • Meta-Analysis of Dietary Patterns (Shareghfarid et al., 2020):

    • Healthy Patterns: Consisting of fruits, vegetables, fish, and rich in PUFAs and micronutrients (magnesium, zinc, phytochemicals). These decrease ADHD risk by 37%37\% (OR: 0.630.63; 95% CI95\%\,CI: 0.41−0.960.41-0.96).

    • Western Pattern: Rich in red and processed meats, refined grains, soft drinks, and hydrogenated fats. It increases risk by 92%92\% (OR: 1.921.92; 95% CI95\%\,CI: 1.13−3.261.13-3.26; p=0.016p = 0.016).

    • Junk Food Pattern: Characterized by high consumption of processed foods, high artificial food coloring (AFC), and sugar. It increases risk by 51%51\% (OR: 1.511.51; 95% CI95\%\,CI: 1.06−2.161.06-2.16; p=0.024p = 0.024).

  • Mediterranean Diet: Ríos-Hernández et al. found that lower adherence to this diet was associated with an ADHD diagnosis in Spanish children (OR: 7.077.07; 95% CI95\%\,CI: 2.65−18.842.65-18.84).

  • Vegetarian Diets: A large survey in Ma’anshan city, China (N=14,912N = 14,912), showed the "Vegetarian" pattern was negatively correlated with ADHD symptoms (OR = 0.670.67).

  • Artificial Food Coloring (AFC): AFC consumption has quadrupled in the last 5050 years. Evidence suggests it may affect brainwave activity and ADHD symptoms (Schab & Trinh found an overall effect size of 0.2830.283 for AFCs on hyperactivity).

Specific Foods, Nutrients, and Trace Elements

  • Sugar and Sweetened Beverages: A study of school-age children in Korea linked high intake of sweetened desserts, fried foods, and salt to attention problems. Farsad-Naeimi et al. found that sweetened beverages increased the odds of ADHD symptoms by 40%40\% in children over 77 years old, though dietary sugars alone did not consistently increase risk.

  • Trace Elements: Children with ADHD often present with reduced plasma levels of elements essential for brain function:

    • Iron: A cofactor for neurotransmitter metabolism, particularly dopamine production.

    • Zinc: Required for metabolism of neurotransmitters, melatonin, and prostaglandins.

    • Others: Copper, magnesium, and selenium.

  • Vitamins:

    • Vitamin D: Meta-analysis shows low status is significantly associated with ADHD (OR: 2.572.57). Perinatal suboptimal levels are associated with a higher risk in later life (RR: 1.401.40).

    • Vitamin A: Serum concentrations of retinol linked with disorder severity, especially when co-deficient with Vitamin D.

  • Polyunsaturated Fatty Acids (PUFAs): ADHD patients often have lower levels of eicosapentaenoic acid (EPA-C20:5), docosahexaenoic acid (DHA-C22:6), and total n-3 series PUFAs in blood and buccal tissues.

Nutritional Supplement Interventions

  • Vitamin D: Supplementation (50,000 IU/week50,000\,IU/week for 6−126-12 weeks) showed significant improvements in total ADHD scores and inattention. However, improvements were not seen in children who had sufficient baseline levels (Dehbokri et al., 2019).

  • Vitamin D + Magnesium: Hemamy et al. (2021) demonstrated that co-supplementation (50,000 IU/week50,000\,IU/week Vitamin D and 6 mg/kg/day6\,mg/kg/day Magnesium) for 88 weeks reduced emotional and conduct problems compared to placebo.

  • Zinc Supplementation:

    • Noorazar et al. (2020) and Zamora et al. (2011): 10 mg/day10\,mg/day for 66 weeks improved Conners scores.

    • Bilici et al. (2004): 40 mg/day40\,mg/day for 1212 weeks improved hyperactive, impulsive, and social symptoms in a sample of 400400 children.

  • Iron Supplementation:

    • Konofal et al. (2008): 80 mg/day80\,mg/day ferrous sulfate for 1212 weeks improved ADHD-RS and CGI-S scores.

    • Panahandeh et al. (2017): 5 mg/kg/day5\,mg/kg/day ferrous sulfate for 88 weeks improved total CSI-4 scores.

Polyunsaturated Fatty Acid (PUFA) Supplementation Results

  • Conflicting Evidence:

    • Chang et al. (2018): Meta-analysis of 77 RCTs showed n-3 PUFAs improve symptoms with a modest effect size (g=0.38g = 0.38). Hyperactivity symptoms only improved with EPA doses exceeding 500 mg500\,mg.

    • Handel et al. (2021): Meta-analysis of 3131 RCTs (17551755 patients) found no significant effect of PUFA on core ADHD symptoms, quality of life, or behavioral difficulties.

  • Specific Studies:

    • Dopfner et al. (2021): In preschool children at risk for ADHD, daily doses of 372 mg372\,mg EPA, 116 mg116\,mg DHA, and 40 mg40\,mg GLA for 1616 weeks showed moderate improvement in parent- and teacher-rated symptoms (Inattention, externalizing, and emotional reactivity).

    • Carucci et al. (2022): In Italian children with mild ADHD, 279 mg279\,mg EPA, 87 mg87\,mg DHA, and 30 mg30\,mg GLA for 66 months showed no clinical benefit for inattentive symptoms.

Microbiome-Targeted Interventions (Biotics)

  • Microbiota-Gut-Brain Axis: This axis illustrates communication between gut microbiota and the brain. Distinct microbiota profiles have been found in ADHD patients compared to controls.

  • Lactobacillus rhamnosus GG (LGG):

    • Partty et al. (2015): Probiotic intervention early in life reduced the long-term risk of ADHD and Asperger syndrome development.

    • Kumperscak et al. (2020): Daily LGG (1010 CFU10^{10}\,CFU) for 1212 weeks improved self-reported health-related quality of life in children and adolescents.

  • Multi-Species Probiotics:

    • Sepehrmanesh et al. (2021): Multi-strain probiotic (8×109 CFU/day8 \times 10^9\,CFU/day including L. reuteri, L. acidophilus, L. fermentum, and B. bifidum) improved ADHD RS and anxiety symptoms over 88 weeks.

    • Ghanaatgar et al. (2022): "Bio-Kult-protexin" capsules (including 14 strains such as B. subtilis, L. casei, and S. thermophiles) significantly improved Conners Parent Rating Scale and CGI-S scores.

  • Synbiotics: Skott et al. (2020) used "Synbiotic 2000" (4×1011 CFU4 \times 10^{11}\,CFU of three lactic acid bacteria and 10 g10\,g fermentable fibers like beta-glucan and inulin). While it did not change core symptoms, it reduced autism symptoms in children with vascular inflammation.

Specialized Diets and Elimination Protocols

  • DASH Diet: Characterized by fruits, vegetables, low-fat dairy, and low sugar. A 12−week12-week RCT in Iran showed improvements in ACS and SNAP-IV scores for ADHD patients.

  • Elimination Diets (ED):

    • Forms: Single-food exclusion, multi-food exclusion, and "few-foods diet" (oligoantigenic diet).

    • INCA Study (Pelsser et al., 2011): A RCT involving 55 weeks of a restricted elimination diet. Clinical responders (40%40\% improvement on ARS) entered a challenge phase. Relay of symptoms occurred in 63%63\% of children regardless of dietary IgG levels, suggesting that IgG blood tests do not predict food triggers.

    • Few-Foods Diet (FFD): Associated with a reduction in physical complaints (thermoregulation, gastrointestinal, eczema, sleep) in ADHD children. Parent ratings showed a high effect size (0.800.80).

    • Oligoantigenic Diet (OD): Dolp et al. (2020) found improvements in ARS scores via video-rating evaluation of 8 children during a reintroduction phase.

  • TRACE Study: An ongoing two-arm RCT in the Netherlands comparing short- and long-term effects of an elimination diet versus a healthy diet in children with ADHD.

Discussion and Clinical Implementation

  • Methodological Limitations: Observational studies cannot prove causality. Short intervention periods, lack of randomization in some pilot trials, and measurement errors in food frequency questionnaires limit the robustness of the evidence.

  • Subgroup Effects: Diet interventions may only be effective for specific subgroups of patients (e.g., those with nutritional deficiencies or specific food sensitivities).

  • Precautions and Risks: Highly restrictive diets (Elimination or Few-Foods) carry a high risk for nutritional deficiencies and poor physical growth. They must be strictly supervised and monitored.

  • Comparison to IBS: These restrictive diets are compared to the low-FODMAP diet used in Irritable Bowel Syndrome, which is only recommended for specific cases under rigorous supervision.

  • Precision Medicine: Due to phenotypic heterogeneity, a personalized medicine approach is necessary for ADHD dietary therapy.

  • Chapter 34: Overview and Learning Objectives of Child and Adolescent Psychiatry

    • Core Categories and Frequency: Identification and description of the major categories of psychiatric disorders in children and adolescents, including the relative frequency of serious disorders.

    • Genetic and Environmental Influences: Analysis of factors associated with the development of psychiatric disorders, including biological, neurophysiologic, psychosocial, cultural, and contextual factors.

    • Symptomatology: Detailed description of symptoms for selected child and adolescent psychiatric disorders.

    • Nursing Principles: Identification of principles for nursing intervention, including psychotherapeutic management and psychopharmacology.

    Developmental and Contextual Considerations

    • Developmental Stages: Assessment must account for the child's current developmental progress and age-appropriate behaviors.

    • Biological and Neurophysiologic Factors: Understanding brain development and physiological predispositions.

    • Psychosocial Influences: Impact of the environment, family dynamics, and social circles.

    • Cultural Factors: Contextual influences that shape the expression and perception of mental health symptoms.

    Major Psychiatric Disorders in Children and Adolescents

    • Attention-Deficit Hyperactive Disorder (ADHD): Characterized by high levels of inattention, hyperactivity, and impulsivity.

    • Oppositional Defiant Disorder (ODD) and Conduct Disorder: Behavioral disorders involving defiance of authority and violation of social norms.

    • Depressive Disorders: Including both unipolar and bipolar depression.

    • Bipolar Disorder (BPD) and Disruptive Mood Dysregulation Disorder (DMDD): Disorders involving extreme mood fluctuations or chronic, severe irritability.

    • Anxiety Disorders: Including Pediatric Obsessive-Compulsive Disorder (OCD) and Posttraumatic Stress Disorder (PTSD).

    • Autism Spectrum Disorder (ASD): Defined by social interaction deficits and repetitive behaviors.

    • Additional Areas of Clinical Focus:

      • Gender Dysphoria

      • Eating disorders

      • Tic Disorders (e.g., Tourette’s)

      • Bullying

      • Substance Use

      • Neurodevelopmental and psychotic disorders

    Bullying

    • Definition: Intentionally cruel and unprovoked behavior directed towards a peer.

    • Verbal Bullying: Includes slander and name-calling.

    • Relational Bullying: Characterized by shunning or ignoring the victim to cause social isolation.

    • Physical Bullying: Ranges from slight shoving to severe violence resulting in burns or broken bones.

    • Cyberbullying: Abusive behavior in cyberspace involving emails, texts, forwarding private communications/pictures without permission, or spreading rumors via social networking websites.

    • Nursing Role: Nurses must identify bullying behaviors and take appropriate action to protect the victim and intervene with the perpetrator.

    Vulnerability to Psychiatric Disorders

    • Contributing Factors:

      • Family Genetics: Hereditary predispositions to mental illness.

      • Adverse Family Circumstances: Environmental stressors within the home.

      • Comorbid Emotional Health Concerns: Presence of multiple mental health issues simultaneously.

    • Resilience: The ability to recover from or adjust easily to misfortune or change.

      • Nurses must assess what makes a child more resilient and what factors increase or decrease their overall risk.

    Attention-Deficit Hyperactive Disorder (ADHD)

    • Hallmark Symptoms: Three primary symptoms include hyperactivity, impulsivity, and inattention.

    • Diagnosis Requirements: Symptoms must be present in at least 22 or more settings (e.g., home and school).

    • Nursing Assessment and Interventions:

      • Medical Screening: Physical examination to rule out underlying medical conditions.

      • Sleep Hygiene: Assess for and treat sleep issues.

      • Nutrition: Improve nutrition and avoid identified "trigger" foods.

      • Physical Activity: Ensure the child receives at least 11 hour of exercise daily.

      • Environmental Structure: Establish routines and schedules shared with the child (avoiding overly rigid regimens).

      • Behavioral Assessment: Monitor for potential anger and aggression.

      • Pharmacology: Collaborate with MD/NP to prescribe appropriate medications.

    Disruptive Behavioral Disorders

    Oppositional Defiant Disorder (ODD)

    • Confirmation Criteria: A persistent pattern of angry mood symptoms and argumentative or defiant behavior.

    • Symptoms:

      • Loses temper often.

      • Touchy or easily annoyed.

      • Resentful or angry.

      • Argumentative with authority figures.

      • Deliberately annoys others.

      • Blames others for mistakes.

      • Spiteful or vindictive at least twice in the past 66 months.

    Conduct Disorder

    • Prevalence: Significantly more common in males.

    • Definition: A repetitive pattern where the basic rights of others or societal rules are violated.

    • Key Behavioral Categories:

      1. Aggression toward people and animals.

      2. Destruction of property.

      3. Deceitfulness or theft.

      4. Serious violations of rules.

    Depression and Mood Disorders

    • Prevalence: Approximately 12.5%12.5\% of youth experience depression by age 1818. After puberty, rates in girls increase more rapidly.

    • Symptoms:

      • Feelings of helplessness and hopelessness.

      • Low energy and social withdrawal.

      • Hallmark Symptom: Frequent irritability is often more prominent than sadness in children.

      • Presence of possible suicidal ideation.

    Bipolar Disorder (BPD)

    • Presentation: Involves extreme changes in mood and behavior. It differs from adult presentation as irritability is a very prominent symptom.

    • Phases:

      • Depressive Phase: Sad, "down," and much less active than usual.

      • Manic Phase: Very happy or "up," more energetic and active than usual.

    • Impact: Affects sleep, energy levels, and the ability to think clearly.

    Disruptive Mood Dysregulation Disorder (DMDD)

    • DSM-5 Criteria: Established for children who are chronically irritable or angry most of the day and have severe, recurrent temper outbursts (verbal or physical).

    • Diagnosis Constraints:

      • Onset must be prior to age 1010.

      • Cannot be diagnosed for the first time in children under age 66 or adults over 1818.

      • Criteria for Bipolar Disorder are not met.

    Leading Causes of Death by Age Group

    • Ages 1–4 Years:

      1. Accidents (unintentional injuries).

      2. Congenital malformations, deformations, and chromosomal abnormalities.

      3. Assault (homicide).

    • Ages 5–9 Years:

      1. Accidents (unintentional injuries).

      2. Cancer.

      3. Congenital malformations, deformations, and chromosomal abnormalities.

    • Ages 10–14 Years:

      1. Accidents (unintentional injuries).

      2. Intentional self-harm (suicide).

      3. Cancer.

    • Ages 15–19 Years:

      1. Accidents (unintentional injuries).

      2. Homicide.

      3. Suicide.

    • Source: National Vital Statistics System – Mortality data (2022) via CDC WONDER.

    Anxiety Disorders

    • Lifetime Prevalence: Ranges between 15%15\% and 32%32\%.

    • Pediatric OCD:

      • Involves recurring thoughts (obsessions) and ritualistic behaviors (compulsions) intended to decrease anxiety.

      • Features include perfectionism, intolerance for uncertainty, and overestimation of threat.

      • Associated with Tic disorders (Tourette’s).

    • PTSD:

      • Symptoms are similar to adults: nightmares, intrusive memories, and hypervigilance.

      • Can result from a single event or long-term trauma, either as a victim or a bystander.

    Generational Trauma

    • Definition: Also known as intergenerational or transgenerational trauma; the transmission of traumatic effects across generations.

    • Large-Scale Examples:

      • Families of Holocaust survivors.

      • Indigenous communities affected by colonization.

      • African American communities impacted by slavery and systemic racism.

      • Families affected by war, displacement, or poverty.

    • Family-Scale Examples: Cycles of abuse, neglect, or addiction repeated across generations.

    Autism Spectrum Disorder (ASD)

    • Presentation: More common in males. Characterized by persistent deficits in social interaction, impaired communication, and restricted, repetitive behaviors or interests.

    • Diagnosis Timing: Symptoms must be present early in childhood, though they may not manifest fully until social demands exceed the child's capacity.

    • Causal Factors and Environmental Triggers:

      • Prenatal Valproate Exposure: Strongly linked to higher ASD risk; FDA warns against use in pregnancy unless essential.

      • Maternal Infection/Fever: Maternal immune activation/fever during pregnancy is associated with a ∼30%\sim 30\% increase in ASD odds.

      • Air Pollution: Exposure to PM2.5 during pregnancy is linked to increased risk.

      • Pesticide Exposure: Residential proximity to agricultural organophosphates during gestation.

      • Inconclusive Data: Acetaminophen and SSRI use in pregnancy have mixed data; confounding factors like maternal illness severity or fever make these associations uncertain.

    Psychotherapeutic Management and Nursing Care

    • Nurse-Patient Relationship: Founded on empathy, honesty, and consistency for both the patient and their family.

    • Mental Health Literacy: Educating families on psychiatric conditions.

    • Milieu Management: Focuses on five primary environmental issues:

      1. Safety: Protecting the child and others.

      2. Structure: Predictable routines.

      3. Norms: Expected behaviors and social standards.

      4. Limit Setting: Maintaining clear boundaries.

      5. Balance: Balancing independence with support.

    • Therapeutic Modalities:

      • Individual interactive therapy

      • Group and Family therapy

      • Recreational, Occupational, Music, and Art therapy

      • Cognitive-Behavioral Therapy (CBT)

      • School-based activities

    Psychopharmacology for Children and Adolescents

    General Principles

    • Approach must be conservative.

    • Collaboration with adult caregivers is essential.

    • Dosages are typically based on both age and weight.

    Antidepressants (SSRIs)

    • Fluoxetine (Prozac): Approved for depression for age 88 and above; approved for OCD for age 77 and above.

    • Escitalopram (Lexapro): Approved for depression for age 1212 and above.

    • Sertraline (Zoloft): Approved for OCD for age 66 and above.

    • Fluvoxamine (Luvox): Approved for OCD for age 88 and above.

    • Duloxetine (Cymbalta): Approved for Generalized Anxiety Disorder (GAD) for age 77 and older.

    • Warning: FDA warning for increased suicidal thoughts/behaviors in patients under 2525 years old.

    Tricyclic Antidepressants (TCAs)

    • Used for depression, anxiety, ADHD, and nocturnal enuresis.

    • Examples: Amitriptyline (Elavil), Desipramine (Norpramin), Imipramine (Tofranil), Nortriptyline (Aventyl).

    • Cautions: Less commonly used than SSRIs due to side effects. Baseline and repeated cardiograms (ECGs) are required due to potential cardiac toxicity.

    Medications for Bipolar Disorder

    • Atypical Antipsychotics (Ages 10–17): Aripiprazole (Abilify), Quetiapine (Seroquel), Risperidone (Risperdal).

    • Atypical Antipsychotics (Ages 13–17): Olanzapine (Zyprexa).

    • Lithium: Approved for age 1212 and above; typically not a first-line agent.

    • Other Mood Stabilizers: Oxcarbazepine (Trileptal) and Valproic acid (Depakote) (used off-label).

    Medications for ADHD

    • Psychostimulants (First-line):

      • Class 1: Dextroamphetamine (Dexedrine), Methylphenidate (Ritalin; Concerta—long acting).

      • Class 2: Dextroamphetamine and amphetamine salts (Adderall).

    • Alpha-2 Agonists: Clonidine (Catapres) or Guanfacine (Tenex).

    Medications for Autism Spectrum Disorder (ASD)

    • No specific psychotherapy or medication treats the core ASD social deficits.

    • Ancillary Symptoms: Medications treat anxiety, depression, and agitation resulting from ASD stress.

    • Atypical Antipsychotics for Aggression/Agitation: Aripiprazole (Abilify), Risperidone (Risperdal), Olanzapine (Zyprexa), Quetiapine (Seroquel), Ziprasidone (Geodon).

    Case Study: Bradley

    • Presentation: 88-year-old Bradley is overactive, intrusive, angry, and unable to take directions. He cannot settle down, cannot sit long enough for school work, fidgets constantly, and has angry outbursts when frustrated.

    • Patient Perspective: Bradley states, "I can’t think because I can’t sit still. That’s why I get so mad."

    • Diagnosis: Based on these behaviors, the most likely diagnosis is Attention-Deficit Hyperactive Disorder (ADHD).

    Questions and Discussion

    • Question 1: Based on the behaviors described by the mother and the specific concern expressed by Bradley, which diagnosis is most likely?

      • Response: Attention-deficit hyperactive disorder.

    • Question 2: Which of the following is a common symptom of ADHD?

      • Response: Hyperactivity.

    Introduction to Milieu Management

    • Definition of Terms:

      • Therapeutic Milieu: Also referred to as a therapeutic environment or milieu therapy. It is a growth-promoting atmosphere created within a treatment setting.

      • Therapeutic Environment: A setting influenced by the relationships among staff, patients, and visitors, as well as the physical structure of the facility.

      • Milieu Therapy: Refers to the beneficial aspects of the treatment setting that contribute to patient recovery.

    • Goal of Milieu Management:

      • The primary objective is to ensure the protection of patients from potentially harmful effects.

      • It aims to maximize opportunities for patients to learn about themselves and the difficulties they face in everyday living.

      • Recovery-oriented care is the standard goal, enabling individuals to improve health and wellness, live self-directed lives, and strive toward their full potential.

    • Historical Overview:

      • Custodial Care: Historically, patient care focused on Activities of Daily Living (ADLs) and basic safety needs. This model was paternalistic and lacked structured treatment activities.

      • Maxwell Jones (1953): Wrote The Therapeutic Community, which discussed the benefits of a therapeutic environment. He proposed involving patients in decision-making through "therapeutic community meetings."

    • Current Inpatient Acute Facilities:

      • Characteristics include fewer beds, reduced length of stay, and higher acuity of psychotic or detained patients.

      • There is an increased risk of violence in these settings.

      • Purpose of Hospitalization: To contain and resolve crises, provide rapid stabilization of symptoms, and return the patient to community treatment programs.

    Joint Commission Standards for the Environment of Care

    • Safety: Includes equipment management and safety management procedures.

    • Security: Focuses on handling emergencies and interacting with the media.

    • Social Environment: Requires space for grooming and personal property; clothing must be suitable for clinical conditions.

    • Physical Setting: Standards for privacy, respect, door locks, telephones, sleeping rooms with doors, and access to the outdoors.

    • Case Study 1 (Application): On a Behavioral Care Unit, features such as casual clothing, clean furnishings, porch access, semi-private rooms with doors, and full bathrooms are elements regulated or influenced by Joint Commission standards.

    Nursing Role in the Therapeutic Environment

    • Foundations: Florence Nightingale first recognized the importance of the environment on recovery. Nurses are traditionally responsible for managing the unit environment.

    • Therapeutic Relationship: Promotes corrective learning experiences to help patients adapt to daily living problems. It focuses on "here and now" interactions as part of the overall treatment plan.

    • Active Management:

      • Nurses must pay attention to their own personal values, reactions, and preconceptions.

      • The environment is altered to be therapeutic through a coordinated process of structured activities, such as education groups.

    • Nurse Responsibilities:

      • Monitoring patients for safety.

      • Understanding and administering medications.

      • Developing a working rapport with the patient.

    Elements of the Treatment Environment

    • Safety: Physical and psychological protection.

      • Prevention of suicide and verbal or physical aggression.

      • Safety Observations (Rounds): Checking on patients at a frequency determined by unit policy and individual patient needs.

      • Environmental Care: Preventing intrusive behaviors like bullying or entering others' private spaces.

      • Posting patient rights and contact numbers for assistance if rights are violated.

    • Structure: Includes the physical environment, daily schedules, and informal rules.

      • Nurses lead activities like patient education, social skills training, and medication education (side effects/aftercare).

      • Trained therapists lead psychosocial groups, individual therapy, family therapy, art therapy, and occupational therapy.

    • Norms: Expectations of behavior that promote safety and trust.

      • Behaviors must be socially acceptable, consistent, and predictable.

      • Norms apply to all patients and offer a sense of control while averting power struggles.

    • Limit Setting: Approaches for regulating patient behavior.

      • Includes verbal and nonverbal communication by the nurse.

      • Use of fast-acting sedating medications.

      • Environmental modalities include restraints and seclusion to maintain safety and facilitate growth.

    • Balance: Gradually allowing independent behaviors within a dependent situation.

      • The nurse must weigh the needs of the specific patient against those of other patients and staff.

      • Example: Intervening before escalation by spending time with a patient and seeking their perspective to reduce aggression (proactive stance).

    Managing Inpatient Aggression and the Assault Cycle

    • Strategies for Violence Reduction:

      • Enhance the nurse-patient relationship and improve communication.

      • Continually assess the milieu and provide meaningful activities.

      • Maintain safe unit staffing.

      • Nurses must be aware of their own anger and channel it constructively.

      • View aggressive behavior as a form of communication and a call for help.

    • Reduction of Restraints: A 75%75\% reduction in seclusion and restraint events has been achieved through better assessment at admission, staff education, and individualized care plans.

    • The Assault Cycle Framework:

      1. Triggering Phase: A stress-producing event occurs. Nurse intervention: Use empathy, soft speech, and nondirective techniques. Encourage ventilation of feelings.

      2. Escalation Phase: Behaviors indicate a movement toward loss of control (e.g., screaming, swearing). Nurse intervention: Allow time to reduce anxiety, offer oral PRN medications, and suggest a "time-out" in a quiet area.

      3. Crisis Phase: Loss of control; patient attacks environment, self, or others. Nurse intervention: External control is essential via seclusion, restraints, or stat medications. Verbal limits are ineffective here.

      4. Recovery Phase: Cooling down period. Nurse intervention: Assure the patient they are not being punished; encourage relaxation.

      5. Post-Crisis Depression Phase: Reconciliation attempts. Nurse intervention: Discuss the incident and explore alternative handling strategies for the future.

    • Pharmacological Interventions:

      • Oral Antianxiety: Lorazepam (Ativan) and Alprazolam (Xanax) for rapid effect.

      • Antipsychotics: Quetiapine (Seroquel) orally; Haloperidol (Haldol) or Ziprasidone (Geodon) orally or via IM injection.

    Seclusion and Restraint Protocols

    • Seclusion: Placing a patient alone in a lockable room with a security window/camera. Used for containment, decreasing stimulation, and managing disruptive thermal or sexual behaviors.

    • Restraint Implementation:

      • Requires 66 to 88 staff members, potentially including security.

      • Approach with a "show of concern," informing the patient that physical contact is a last resort to help.

      • Physician evaluation must be face-to-face and an order obtained within 1 hour1\text{ hour}.

    • Care During Seclusion/Restraint:

      • Observation: Continuous direct or video monitoring.

      • Assessments: Mental status, medication response, side effects, hydration, nutrition, and elimination.

      • Physical Care: Range of motion (ROM) and skin care every 2 hours2\text{ hours} for a duration of 10 minutes10\text{ minutes} with two staff members present. Monitor vital signs and check for injuries.

      • Stimulus Reduction: Restrict visitors, phone calls, and diversional materials (radios, magazines).

    • Staff Debriefing: Occurs immediately after the incident to assess injuries, evaluate the process, and identify areas for improvement.

    • Documentation: Must be descriptive, sequential, and specific regarding behavior before, during, and after the incident, including the rationale for physical control.

    Suicide Assessment and Intervention

    • Functions of Suicide: Escape, ensuring control, a solution to emotional pain, or a cry for help.

    • Themes: Hopelessness, meaninglessness, and being out of control.

    • Risk Factors: Previous attempts, substance abuse, loss of social support, family history, and recent release from an inpatient setting.

    • Assessment Frequency: On admission, during precaution changes, during mental status or medication changes, and prior to discharge.

    • Suicide Assessment Components: Thoughts, intent, plan, and lethality/accessibility of the plan.

    • Observation Levels:

      • Level 1: Every 15 minutes15\text{ minutes} checks; patient may sign a "No-suicide contract" (not legally binding).

      • Level 2: Uninterrupted, one-to-one (1-to-11\text{-to-}1) observation.

    • Discharge Planning: Inform family of high-risk signs (sleep disturbances, anxiety); document firearm safety instructions; provide prescriptions only until the first follow-up appointment; provide local resources (e.g., 1−800−273−TALK1-800-273-TALK).

    Staff Welfare and Clinical Supervision

    • Secondary Traumatization: Psychiatric nurses may experience fear, anxiety, burnout (emotional exhaustion), or PTSD due to managing violent patients.

    • Symptoms: Disillusionment, cynicism, guilt, nightmares, and irritability.

    • Clinical Supervision: A structured, nonhierarchical mechanism for nurses to reflect on practice, validate decisions, and manage the emotional impact of patient encounters. It is relationship-based and focused on professional development.

    Inpatient and Community Treatment Settings

    • Intensive/Acute Care Units: Locked units for rapid stabilization (24 hour24\text{ hour} structure). Admissions are for those who are a danger to self/others or gravely disabled.

    • Child-Adolescent Units: Focus on family-centered care, schoolwork, and peer play. Includes interdisciplinary teams with dietitians.

    • Substance Abuse Centers: Specialized for detoxification and dual-diagnosis (co-occurring disorders).

    • Geropsychiatric Units: Specialization in Alzheimer’s, fall prevention, and age-related physical changes.

    • State Psychiatric/Forensic Hospitals: Long-term treatment for severe psychosis or individuals convicted of crimes/deemed too dangerous for the community (most restrictive).

    • Community Settings:

      • Group Homes: 66 to 1212 bed homelike milieus staffed by paraprofessionals.

      • Partial Hospitalization: Day services to transition from acute care and reduce rehospitalization.

      • Day Treatment: Focus on rehabilitation, recovery, and maintaining community living function.

    • Treatment Activities:

      • Occupational Therapy: Focus on functional abilities, self-care, work, and play.

      • Recreational Therapy: Balancing work and play; exercise groups.

      • Psychoeducation: Teaching patients/families about symptom management.

      • Spirituality Groups: Led by chaplains; focus on hope, forgiveness, and meaning.

    Defining Trauma and Violence

    • Trauma:

      • Defined as the perception of an imminent threat to an individual's person or livelihood.

      • Results in a subjective experience of feeling "afraid and alone."

      • Trauma is more than a past event; it includes the lasting imprint left on the individual's mind, brain, and body.

    • Violence:

      • Involves physical threat or injury, as well as emotional despair and trauma.

      • Aftereffects of Violence:

        • Loss of trust.

        • Lack of feelings of safety.

        • Anxiety.

        • Hyperarousal (triggering), which may be perceived by others as overreacting.

        • Feelings of shame or contamination.

    The Recovery Process: Stages of Healing

    • Impact Stage:

      • Duration: Lasts minutes to days.

      • Common Responses: Shock, denial, disbelief, confusion, fear, hysteria, horror, anger, shame, and helplessness.

      • Physical/Physiological: Disturbed sleeping and eating patterns.

      • Delayed Reactions: It is possible for reactions to be delayed; occasionally, patients experience dissociative symptoms, intrusive memories, or severe anxiety.

    • Recoil Stage:

      • Duration: Lasts weeks to months.

      • Behavior: Patients struggle to adapt and may have periods of acting "normal."

      • Needs: In the latter portion of this phase, there is a desire to talk about the details and feelings regarding the trauma. The patient requires support and may exhibit temporary dependence.

      • Development: Gradual awareness of the full impact of the event occurs.

    • Reorganization Stage:

      • Duration: Lasts months to years.

      • Progression: Begins with reviewing and organizing what happened and why (blaming and justifying). It progresses to regaining a sense of control and self-protection.

      • Outcome: Resolution of grief occurs. If resolution is not achieved, the remaining symptoms may qualify as Posttraumatic Stress Disorder (PTSD).

    Nurse-Patient Relationship: Intervention by Stage

    • Impact Stage Interventions (Crisis Intervention):

      • Prioritize physical safety and emotional security.

      • Give simple directions; avoid accusations.

      • Provide phone numbers for crisis intervention services.

    • Recoil Stage Interventions:

      • Utilize support groups and short-term counseling.

      • Validate the victim and their rights.

      • Provide referrals to appropriate therapies and victim groups.

    • Reorganization Stage Interventions:

      • Long-term counseling may be needed for potential anxiety, PTSD, or depression.

    Terrorism: Psychosocial Effects and Recovery

    • Typical Emotional Effects:

      • Shock, disbelief, fear, anxiety, and powerlessness.

      • Insecurity, guilt, shame, and spiritual distress.

      • Unresponsiveness, dissociation, and numbness.

      • Panic, terror, violation, anger, and rage.

      • Aggression, fantasies of revenge, and impulsiveness.

      • Helplessness, hopelessness, and despair.

    • Cognitive and Behavioral Effects:

      • Decreased concentration and confusion.

      • Suicidal or homicidal ideation; self-mutilation.

      • Mistrust, suspiciousness, paranoia, and alienation.

      • Estrangement, withdrawal, and isolation.

      • Fatigue, insomnia, nightmares, and flashbacks.

      • Memory disturbances and amnesia.

      • Hyperarousal, stress sensitivity, and startle response.

      • Defense mechanisms: Denial, repression, suppression, and intellectualization.

    • Physical and Long-term Clinical Effects:

      • Body kinesthetic memories and psychosomatic symptoms.

      • Extreme passivity and loss of self-esteem.

      • Depression, prolonged grieving, and substance abuse.

      • Sexual dysfunction, eating disorders, and anxiety disorders.

      • Labile emotions and personality changes.

      • Diagnosis of PTSD.

    • Recovery from Terrorism:

      • Major Goal: Regain a sense of trust, safety, and security.

      • Acknowledgment: Patients must eventually acknowledge that future attacks are possible.

      • Recovery often takes longer than expected.

    Ritual Abuse, Mind Control, and Human Trafficking

    • Ritual Abuse: Defined as systemic, organized sexual, physical, and psychological abuse sustained over a long duration. It involves premeditated torture and multiple abusers; victims are frequently children.

    • Human Trafficking (HT): Control over a person for exploitation (sexual exploitation, forced labor, slavery, servitude, or organ removal). Includes transportation and harboring for profit.

    • Risk Factors:

      • Poverty and homelessness.

      • Young age and limited education.

      • Lack of family support.

      • History of domestic violence or previous abuse (physical, emotional, sexual).

      • Living in high-crime areas.

    • Human Trafficking Tactics: Recruitment may involve offers of money, promises of a "better life," deceptions, threats, coercion, force, or kidnapping.

    • Ritual Abuse Recovery and Treatment:

      • Impact Stage: Ongoing but may wax and wane.

      • Recoil Stage: Adaptation is difficult due to the severity; this stage is often prolonged with relapses during life crises.

      • Aftercare: Requires ongoing advocacy.

    • Treatment Modalities:

      • Cognitive-behavioral therapy (CBT).

      • Dialectical behavior therapy (DBT).

      • Eye Movement Desensitization and Reprocessing (EMDR).

      • Multisystemic therapy.

      • Medication Note: Use of drugs is highly controversial because medication was often used during the original abuse. However, SSRIs may assist with PTSD symptoms.

    • Treatment Goals for Ritual Abuse:

      • Eliminate self-destructive behaviors.

      • Develop emotion management skills for intense feelings.

      • Identify suppressed thoughts/emotions and allow for grieving.

      • Process and integrate memories.

      • Develop boundaries and living skills.

      • Gain a new perspective and reason to live.

    Rape and Sexual Assault: Rights and Care

    • Definitions:

      • Rape: Unwanted, nonconsensual, or forced vaginal, oral, or anal intercourse.

      • Sexual Assault: Any form of forced sexual contact (ranging from touch to mutilation). It is often a fear tactic used to dominate or humiliate rather than a sexually motivated act.

    • Psychosocial Effects:

      • Sleep disturbances, nightmares, and phobias.

      • Anorexia and loss of motivation.

      • Relationship disruptions and suspicion.

      • Self-blame, guilt, shame, and lowered self-esteem.

      • Somatic symptoms.

    • Sexual Assault Nurse Examiners (SANEs): Specialized nurses skilled in collecting forensic evidence while providing empathy and support.

    • Needs and Rights of Rape Survivors (Box 33.2):

      1. Crisis Intervention: Information, counseling, and referrals.

      2. Basic Needs: Housing, transportation, childcare, and safety.

      3. Medical Care: Pregnancy prevention, testing for sexually transmitted diseases (STDs), and follow-up.

      4. Advocacy: Support for choices regarding reporting or prosecuting.

      5. Privacy and Trauma-Informed Care: Confidentiality, gentleness, and clear explanations.

      6. Autonomy: Right to refuse evidence collection and determine who is present during exams.

      7. Legal Rights: Fairness during trials; protection from being asked about prior sexual history with those other than the defendant.

      8. Protection Against Further Harm: Escorts to court, restraining orders, additional patrols, and relocation.

    Childhood Sexual Abuse: Manifestations and Care

    • Childhood Manifestations:

      • Disturbed growth; taking on early protector/caretaker roles.

      • Enuresis, sleep/eating disturbances.

      • Sexualized play or sexual aggression.

      • Running away or truancy.

    • Adolescent Manifestations:

      • Overt dysfunctional coping and impulsive acting out.

      • Self-mutilation and suicide attempts.

      • Prostitution, early marriage, and delinquency.

    • Adult Manifestations by Category (Box 33.3):

      • Identity Issues: Negative self-image, confusion about roles, need for perfection, underachievement or overachievement, need to be totally competent.

      • Relationship Issues: Difficulty connecting, fear of men or women, fear of intimacy or abandonment, difficulty with parenting.

      • Control Issues: Fear of authority and rules, feeling out of control, need to be in control, allowing own children to be abused.

      • Intrusive Thoughts: Intense nightmares, unwanted thoughts, flashbacks (seeing, smelling, hearing).

      • Detachment: Feeling numb or unreal, dissociation ("out-of-body"), feeling as if there are "personalities" inside.

      • Sexual Issues: Discomfort with touch, lack of orgasms, trading sex for favors, promiscuity, or prostitution.

    • Recovery and Nurse-Patient Relationship:

      • Crucial Factor: Developing a secure sense of connection with caring people is vital to recovery.

      • Nurse Actions: Establish trust quickly; ask about abuse in a calm, matter-of-fact way; reassure the victim they are not responsible.

      • Anger-Release Strategies: Talking to an empty chair, journaling, or writing unsent letters.

    Partner Abuse: Helpful Responses and Interventions

    • Clinical Approach:

      • Ask directly if abuse is occurring.

      • Be nonjudgmental, objective, and nonthreatening.

      • Acknowledge the seriousness and do not blame the victim.

      • Do not push the victim to leave or separate before they are ready.

      • Never refuse help if the victim chooses to stay with the abuser.

    • Nursing Interventions:

      • Advise the use of a shelter or safe house if danger is present.

      • Teach about the inevitability of the "Cycle of Violence."

      • Develop a safety/escape plan and provide emergency phone numbers.

      • Inform about legal protections and advocate for personal rights.

    Mental Health in Older Adults

    • Barriers to Care:

      • Patient Barriers: Stereotypes about aging, seeing mental illness as weakness, fear of losing control or institutionalization, and transportation issues.

      • Provider Barriers: Scarcity of geriatric specialists, ageism, and misattributing mental health issues as "just part of aging."

      • Systemic/Economic: Lack of coordination between primary care and mental health; insurance limits; medication affordability.

    • Prevalent Disorders:

      • Depression: Most prevalent along with anxiety. Individuals 5555 years and older have a prevalence of 10%10\% to 16%16\%.

      • Suicide: Incidence increases with age. White men over age 6565 have the highest rate. Chronic suicide involves slower means like refusing food or inconsistent medication use.

      • Schizophrenia: The third leading cause of disability-adjusted years for those 6060 and older.

    • Communication Techniques:

      • Don't rush; allow time for answers.

      • Use the patient's title and surname (e.g., Mr. or Mrs.).

      • Face the patient and articulate clearly; provide hearing aids or glasses if needed.

      • Establish rapport with a handshake and eye contact.

    Pharmacokinetics and Milieu Management for Older Adults

    • Pharmacokinetic Changes:

      • Delayed absorption of oral medication.

      • Extended half-life for lipid-soluble drugs (accumulation in adipose tissue).

      • ↓\downarrow Total plasma albumin leading to ↓\downarrow protein binding sites, resulting in increased free/active drug levels.

      • Possible ↓\downarrow liver metabolism.

      • Reduced renal clearance; creatinine clearance may be reduced even if serum creatinine levels appear normal due to ↓\downarrow lean body weight.

    • Drug Use Guidelines:

      • Start low, go slow: Initial doses should be 13\frac{1}{3} to 12\frac{1}{2} of the standard adult dose.

      • Simplify dosing schedules to a daily dose.

      • Taper off medications; do not discontinue abruptly.

    • Milieu and Environmental Management:

      • Safety: Nonslip floors, grab bars, shower stools, and safe water temperatures.

      • Orientation: Large-print books, non-glare lighting, and high-contrast vivid colors.

      • Socialization: Using furniture that promotes communication; respecting personal space and privacy.

    Questions & Discussion

    • Q: Which manifestation of childhood sexual abuse leads to identity issues as an adult?

    • A: Negative self-image. (Note: Promiscuity leads to sexual issues; fear of authority leads to control issues; difficulty connecting leads to relationship issues.)

    • Q: Which intervention provides a rape survivor protection against further harm?

    • A: Restraining order. (Note: This category also includes escorts to court and relocation.)

    • Q: What is the most appropriate response to a child (Emma, age 66) explaining abuse?

    • A: "You’re in a safe place now, Emma, where you can talk about what’s been happening."

    • Q: What is a major risk factor for an adult survivor of childhood sexual abuse who does not seek treatment?

    • A: Neglect and abuse of their own children. (Note: PTSD, eating disorders, and suicide are risks regardless of treatment status, whereas child abuse patterns are specifically linked to the lack of appropriate intervention.)

    • Therapeutic Goals and Purposes of Clinical Groups

      • Focus on Immediate Issues: Clinical groups are designed to deal with current "here and now" issues affecting patients.

      • Awareness and Knowledge: Groups provide a setting where patients can gain awareness and knowledge regarding their maladaptive thoughts and behaviors.

      • Decision-Making and Problem-Solving: Group settings assist patients in developing decision-making and problem-solving skills.

      • Educational and Skill Development: Specific groups are tailored for education and the development of interpersonal or coping skills.

      • Family Groups: These groups focus on teaching families about mental illness and assisting them in coping with the challenges faced by their family member.

      • General Patient Benefits:

        • Gaining knowledge about relating and communicating with others.

        • Receiving acceptance, reassurance, and support from peers.

        • Gaining hope and a sense of efficacy.

        • Opportunities to test new behaviors in a safe environment.

        • Sharing feelings and problems within a protected setting.

        • Obtaining reaffirmation of personal strengths and increased self-esteem.

        • Experiencing increased self-worth and importance.

      Eleven Specific Therapeutic Factors in Group Therapy

      • Instillation of Hope: Patients observe the progress of others and develop the belief that they can also improve.

      • Universality: The realization that one is not alone and that others experience similar struggles and problems.

      • Imparting of Information: The formal or informal sharing of knowledge, advice, or suggestions by the leader or group members.

      • Altruism: The experience of being useful to others, which can improve a patient’s self-esteem.

      • Corrective Recapitulation of the Primary Family Group: Group members often interact in ways that mirror their family dynamics, allowing them to work through unresolved family issues in a therapeutic way.

      • Development of Socialization Techniques: Learning and practicing fundamental social skills.

      • Imitative Behavior: Members selectively model the healthy behaviors displayed by the leader or other group members.

      • Catharsis: Patients are taught to express deep-seated feelings appropriately in a supportive environment.

      • Existential Factors: Dealing with ultimate concerns such as isolation, death, or the limits of one’s control over life events.

      • Cohesiveness: The sense of belonging and togetherness within the group.

      • Interpersonal Feelings: Exploring and understanding the feelings that occur between group members.

      Primary Classifications of Therapeutic Groups

      • Psychoeducational Groups: These groups teach a variety of content and skills. Common topics include medications and problem-solving techniques.

      • Maintenance Groups: Designed to provide ongoing support, respond to immediate needs, reinforce personal strengths, and provide reality orientation.

      • Activity Groups: These facilitate interaction and self-expression through recreation, exercise, or creative tasks to increase self-esteem.

      • Self-Help and Special Problem Groups: These consist of members who share a common specific problem. Features include:

        • Focus: Helping individuals with a specific issue (e.g., substance use, specific diagnoses).

        • Homogeneity: All members share a similar problem, leading to greater acceptance and understanding.

        • Reduced Isolation: Shared experiences reduce feelings of being alone.

        • Collaborative Brainstorming: Members are more willing to share strategies for coping.

        • Specialized Leadership: The leader is often highly skilled or specialized in that specific problem area.

      Nursing Leadership and Technical Management of Groups

      • Spontaneous vs. Formal Groups:

        • Spontaneous/Informal: Nurses engage in unplanned interactions in common day areas, such as during a card game.

        • Formal: These are planned and structured sessions.

      • Leadership Responsibilities:

        • Use group leadership skills to meet interpersonal needs in a therapeutic milieu.

        • Maintain effective communication throughout the entire shift.

        • Be active, empathic, and provide necessary structure.

        • Ensure groups are goal-directed and stay focused on the "here and now."

      • Session Management Issues:

        • Facilitative Communication: Using techniques that encourage open dialogue.

        • Role Modeling: Demonstrating healthy interpersonal behaviors.

        • Confidentiality: Ensuring the privacy of group discussions.

        • Physical Setting: Managing the environment where the group meets.

        • Group Norms: Establishing rules such as arriving on time and remaining for the entire session.

      • Structure of a Session:

        • The leader states the group’s purpose at the start.

        • The final 55 to 10 minutes10 \text{ minutes} must be reserved to summarize and close the session.

        • The leader should summarize positive feedback provided during the group.

      Management of Challenging Patient Behaviors in Groups

      • The Dominant Patient: This individual monopolizes the session. Nurses should use gate-keeping techniques to ensure other patients have the opportunity to contribute.

      • The Uninvolved Patient: This individual remains quiet or withdrawn. Support them by emphasizing that every individual is important and capable of helping others through their perspective. Use respect and recognition.

      • The Hostile Patient: Use support to help the patient address underlying feelings of fear, self-anger, or unresolved anger directed at others.

      • The Distracting Patient: Use empathy to focus on the underlying need and the present reality, then refocus the group on the task at hand.

      Case Studies and Reflective Discussion: Chapter 10

      • Case Study 1 (John and Anne):

        • Scenario: John and Anne’s daughter has bipolar disorder. They feel embarrassed and do not understand the condition, asking how they can help when they do not understand what is going on.

        • Audience Response (Directing Information): The nurse could direct them to a Psychoeducation group, a Maintenance group, a Self-help group, or an Activity group.

      • Case Study 2 (John and Anne Continued):

        • Scenario: After attending psychoeducational sessions, they prepare for a self-help group for parents of youth with bipolar disorder.

        • Reflective Goal: Goals might include finding a community that understands their embarrassment and learning shared strategies for daily management.

      • Case Study 3 (Andre):

        • Scenario: Andre is angry, feels the staff is not listening to him or giving him proper medications, and confronts co-leaders at a problem-solving meeting.

        • Audience Response (Recommended Response): "Andre, I will help you discuss your problems with the staff after the group with the staff members involved."

      Comparison: Over-the-Counter (OTC) Drugs vs. Alternative Preparations

      • Over-the-Counter (OTC) Drugs and Supplements:

        • Require FDAFDA approval based on sound research.

        • Often called "nonprescription," though this term can apply to both OTC and alternatives.

        • Considered "Conventional therapy."

      • Alternative Preparations:

        • Primarily consist of herbals and nutritional supplements.

        • Classified as part of Complementary Alternative Medicine (CAMCAM).

        • Often naturally derived rather than synthetic.

      • Reasons for Choosing Herbals:

        • Desire for empowerment/self-care.

        • Belief in enhanced health when used with conventional meds.

        • Desire for novel therapies.

        • Skepticism that conventional medicine will help.

        • Advice from health care professionals.

        • High costs of conventional treatments.

        • The assumption that "natural" equates to being better tolerated.

      Risks and Interactions of Common OTC Medications

      • Cold, Cough, Allergy, and Bronchodilator Drugs: Ingredients like phenylephrine and pseudoephedrine interact dangerously with MAOIsMAOIs and stimulants.

      • Nicotine Products: Nicotine and cessation products increase the clearance of many psychotropic medications.

      • Caffeine: May cause elevated blood pressure and heart rate.

      • NSAIDs: Concurrent use of SSRIsSSRIs and NSAIDsNSAIDs increases the risk of gastric bleeding.

      Psychotropic Herbal Therapies: Indications and Risks

      • St. John’s Wort ( Hypericum perforatum ):

        • Use: Mild to moderate depression.

        • Risks: Increases risk for Serotonin Syndrome if taken with SSRIsSSRIs. Interferes with protease inhibitors. Reduces the effectiveness of oral contraceptives.

      • SAM-e ( S-adenosylmethionine ):

        • Use: Shows promise as an adjuvant therapy only.

        • Risks: Risk of Serotonin Syndrome if used with MAOIsMAOIs.

      • Kava ( Piper methysticum ):

        • Action: Inhibits monoamine oxidase BB; binds to benzodiazepine receptors.

        • Risks: Hepatotoxic. Interacts with antiparkinsonian drugs, benzodiazepines, and other CNSCNS depressants.

      • Valerian ( Valeriana officinalis ):

        • Use: Anxiolytic and effective for sleep disorders; often used with St. John’s wort.

        • Risks: Potential for dependence. Negates the effects of MAOIsMAOIs, warfarin, and phenytoin.

      • Chamomile:

        • Use: Sedation and anxiolysis.

        • Risks: Hypersensitivity risk; caution with anticoagulants and CNSCNS drugs.

      • Angelica:

        • Risks: Cardiovascular and gastrointestinal effects; increased sensitivity. Increases PTTPTT (Partial Thromboplastin Time) when used with anticoagulants.

      • Ashwagandha:

        • Use: Anxiolytic.

        • Risks: Exercise caution when used with hypertensives.

      • Ginkgo ( Ginkgo biloba ):

        • Findings: Studies show no significant decrease in the incidence of Alzheimer’s disease.

        • Use: Effective antidote for erectile dysfunction caused by antidepressants.

        • Risks: Increases effects of anticoagulants; use caution in patients with bleeding problems. Interacts with several other drugs.

      • Ginseng: Can exacerbate mania, anxiety, and insomnia.

      • Yohimbine: Can cause nervousness, irritability, and insomnia.

      • General Caution: All herbals should be used with caution if taking Tricyclic Antidepressants (TCAsTCAs), valproic acid, or lithium.

      Vitamins, Minerals, and Nutritional Supplements in Mental Health

      • Melatonin:

        • An endogenous biomolecule and antioxidant that regulates the circadian rhythm.

        • Reduces sleep onset latency and helps with sleep duration, quality, and reduces nocturnal awakenings.

      • Vitamin C and Vitamin E: Associated with a reduced risk of cognitive decline.

      • Vitamin D: May alleviate symptoms of depression.

      • Folate ( Vitamin B9B_9 ): Augmentation can increase the patient’s response to antidepressants.

      • Other B Vitamins: Niacin (B3B_3), Pyridoxine (B6B_6), Cyanocobalamin (B12B_{12}).

      • Omega-3 Fatty Acids:

        • Not synthesized by humans; must come from fish oil or flaxseed.

        • Helps ameliorate symptoms of depression.

        • Positive results found in studies for depression, Schizophrenia, ADHDADHD, Autism, and Substance Use Disorders.

        • Bipolar Disorder: Best evidence points to utility in the predominantly depressed type of bipolar disorder.

      Demographics, Safety Standards, and Future of Integrative Healthcare

      • Usage Statistics:

        • 16%16\% of individuals using prescription medications also take at least one herbal or nutritional supplement.

        • Older adults represent the largest consumer group.

        • Fewer than 310\frac{3}{10} patients disclose supplement use to their providers.

      • Safety and Regulation:

        • Significant variability exists among manufacturers.

        • American Herbal Association (AHAAHA) and American Botanical Council (ABCABC): Promote responsible use and attempt regulation, but lack actual authority.

        • United Pharmacopeial Convention (UPCUPC): A program where manufacturers submit products for testing; passing products receive a seal of approval.

      • Future Directions:

        • Requires investment in regulation, standardization, and research.

        • Need for collaborative partnerships between botanical and conventional medicine.

        • More emphasis on "Integrative Medicine" within the curricula of health profession schools.

      • Media and Cultural Context:

        • Mentions of Babe Rainbow and Ashwagandha.

        • Case study of "fake wellness guru" Belle Gibson, as documented in "The Woman Who Fooled the World" by Beau Donelly and Nick Toscano.

      Case Studies and Reflective Discussion: Chapter 19

      • Audience Response Question 1 (Valerian):

        • Scenario: Jeffrey is trying valerian for sleep.

        • Key Information: Valerian may have a potential for dependence and withdrawal.

      • Case Study 2 (Jeffrey):

        • Scenario: Jeffrey has improved his sleep hygiene (going to bed by 11 P.M.11 \text{ P.M.}, stopping study at 10 P.M.10 \text{ P.M.}, relaxing, stretching, music), but still cannot fall or stay asleep.

        • Audience Response Question 2 (Sleep Solution):

        • Question: Which solution would most likely be recommended?

        • Answer: C. Melatonin (over Niacin, Pyridoxine, or Cyanocobalamin).

      • Nursing Role: The nurse must be proactive in eliciting supplement information from patients with a sense of respect, openness, and interest.